Roche, Hologic, and Thermo Fisher Scientific are among the molecular diagnostic vendors that have received EUAs, or emergency use authorizations, for their tests for the novel coronavirus COVID-19.  

In the United States alone, there are roughly 38,000 patents containing the terms artificial intelligence or machine learning (excluding overlap terms). Of all the fields where artificial intelligence (AI) is promising, healthcare seems to be essential. This is because healthcare systems are plagued with problems of staff shortages, ineffective treatments, and increased patient loads and incorrect diagnoses, all of which to a degree could be helped by new technology.  

In vitro diagnostic testing costs little to the healthcare system and contributes much to clinical practice.  

In vitro diagnostics (IVD) is a growing market, which is one of the reasons that so many companies need to continue to track the market using market research aids. In our latest study The Worldwide Market for In Vitro Diagnostic Tests: 12 Edition, Kalorama Information estimates the in vitro diagnostics market size at $69 billion and growing at 4%, with many sectors of the IVD market growing double that.  

President Donald Trump’s stated goal of lowering drug prices won’t be easy. The President told drugmakers at a White House meeting that prices were “astronomical” and hinted at negotiating with Medicare and reducing regulation on new drugs. Congress has also proposed more generic drugs as a way of saving on costs.

While lower drug prices is an admirable goal, an across-the-board reduction of pharmaceutical prices will face many obstacles and most likely would not happen, according to our research at Kalorama Information. If somehow, Congress and the administration were able to achieve a reduction, it might impair the creation of new drugs.

The outbreak of a hospital associated infection (HAI) known as CRE (carbapenem-resistant enterobacteriaceae) has raised concerns about hospitals and the medical devices they use. However, it is often the case that a problem for one business is an opportunity for another. With hospital infections on the rise, there is now a focus on services that can help hospitals sterilize facilities and devices.

Healthcare market research publisher Kalorama Information has identified the top five trends in the healthcare field that made an impact in 2014 and will continue to be an influence throughout 2015. Kalorama compiled its list based on news events, growth rates of markets the firm studied in 2014, and information requests the firm receives from industry participants. 

Growth in the $54.6 billion in vitro diagnostics (IVD) market during 2013 came from emerging markets while developed nation markets grew at a much slower pace. All of the major IVD companies reported large increases in the top seven emerging markets. This is mostly fueled by privatization and health insurance initiatives by governments and employers. Medicare price cutting in the U.S. is expected to continue, and the IVD market in Europe should remain essentially flat for the next few years. 

According to Kalorama Information’s biennial survey of the IVD industry, The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition, China, Brazil and Korea were among the countries that received industry interest in the form of acquisitions, partnerships and expanded sales efforts.

The diseases that can affect cattle, pigs and other livestock and endanger the food supply are numerous, yet still growing. Swine fever, neosporosis, foot-and-mouth disease and other diseases are among the threats to animals that humans eat. Test makers have answered the call to develop products that can help food manufacturers and government agencies protect livestock and ensure a safe food supply at the beginning of the chain. For this reason, the Veterinary Diagnostics market can expect healthy revenue growth, according to insights from a Kalorama Information report on the topic.

Few industries will be challenged in the coming years like the medical device industry. Many observers project that the overall medical device market may suffer from reduced profits, less venture capital spending, and R&D due to the double-effects of a new excise tax in the United States and reimbursement cuts in world markets. But, this doesn’t mean the whole industry will suffer. Without market research, one might be tempted to generalize the industry, resulting in missed opportunities. Market research reports can help market-watchers find these right opportunities. 

Successful market research is all about asking the right questions. No matter what industry you are in, there are specific questions to consider before diving into your market research. Particularly in the Biotechnology industry, certain factors must be taken into consideration in order to ensure that your research will be the most relevant and effective. Bruce Carlson, Publisher at one of the industry's leading market research producers, Kalorama Information, has laid out three of the most important questions to ask when researching in this field: